With the development and clinical use of antibody-drug conjugates (ADCs) currently gaining significant momentum, the demand for contract development and manufacturing services continues to increase. In response, we have forged a strategic alliance with Simtra BioPharma Solutions to streamline and accelerate the delivery of these targeted therapies and other bioconjugates to patients.

As two industry-leading contract development and manufacturing organizations (CDMOs) in the ADC field, we are united by a shared goal of delivering your drug development program to market more efficiently.

We are bringing together the extensive experience and expertise of each company to meet our clients’ unique needs, from early clinical development to commercial production. Our dedicated teams help to navigate the complexities of your drug development program with confidence.